Evidence map›Paper›PMID 34202294›Full record

ArticleInternational journal of molecular sciences2021

Plumbagin, a Natural Product with Potent Anticancer Activities, Binds to and Inhibits Dihydroorotase, a Key Enzyme in Pyrimidine Biosynthesis.

Hong-Hsiang Guan, Yen-Hua Huang, En-Shyh Lin, Chun-Jung Chen, Cheng-Yang Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Myricetin InhibitsCells · 2026
    Article
  2. Crystal structure of Methanococcus jannaschii dihydroorotase with substrate bound.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  3. Article
  4. Bioactive Potential ofPlants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cytotoxicity and Multi-Enzyme Inhibition ofPlants (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Hong-Hsiang GuanLife Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu 30076, Taiwan.ORCID 0000-0001-5061-165X
Yen-Hua HuangSchool of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec.1, Chien-Kuo N. Rd., Taichung City 402, Taiwan.ORCID 0000-0001-6347-3030
En-Shyh LinDepartment of Beauty Science, National Taichung University of Science and Technology, No. 193, Sec.1, San-Min Rd., Taichung City 403, Taiwan.ORCID 0000-0002-7010-4062
Chun-Jung ChenLife Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu 30076, Taiwan.ORCID 0000-0002-5157-4288
Cheng-Yang HuangSchool of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec.1, Chien-Kuo N. Rd., Taichung City 402, Taiwan.
Chung Shan Medical University · TWChung Shan Medical University Hospital · TWNational Synchrotron Radiation Research Center · TWNational Taichung University of Science and Technology · TWNational Yang Ming Chiao Tung University · TW

Funding

Ministry of Science and Technology, Taiwan 107-2923-B-213-001-MY3 to C.J.C.Ministry of Science and Technology, Taiwan 108-2311-B-213-001-MY3 to C.J.C.Ministry of Science and Technology, Taiwan MOST 108-2320-B-040-010 to C.Y.H.Ministry of Science and Technology, Taiwan MOST 109-2622-E-025-006 to E.S.L.
6 · The paper itself

Abstract

Dihydroorotase (DHOase) is the third enzyme in the de novo biosynthesis pathway for pyrimidine nucleotides, and an attractive target for potential anticancer chemotherapy. By screening plant extracts and performing GC-MS analysis, we identified and characterized that the potent anticancer drug plumbagin (PLU), isolated from the carnivorous plant

Indexed as

Antineoplastic Agents, PhytogenicBinding SitesBiological ProductsBiosynthetic PathwaysCatalytic DomainDihydroorotaseEnzyme InhibitorsModels, MolecularMolecular ConformationMolecular StructureMutationNaphthoquinonesProtein BindingPyrimidinesStructure-Activity RelationshipAntineoplastic Agents, PhytogenicBiological ProductsDihydroorotaseEnzyme InhibitorsNaphthoquinonesplumbaginpyrimidinePyrimidines4T1 cellallantoinaseanticancerCADcrystal structuredihydroorotasedihydropyrimidinasedrug designplumbaginpyrimidine biosynthesis

Identifiers

PMID34202294
PMCPMC8267945
OpenAlexW3174970962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.